Home ProductsMedical Testing Supplies

Sickle Cell Disease Rapid Test, Simultaneous HA/HS/HC Detection for Phenotype Identification

Certification
china Sichuan Hundred Medcal Technology Co., Ltd. certification
china Sichuan Hundred Medcal Technology Co., Ltd. certification
I'm Online Chat Now

Sickle Cell Disease Rapid Test, Simultaneous HA/HS/HC Detection for Phenotype Identification

Sickle Cell Disease Rapid Test, Simultaneous HA/HS/HC Detection for Phenotype Identification
Sickle Cell Disease Rapid Test, Simultaneous HA/HS/HC Detection for Phenotype Identification Sickle Cell Disease Rapid Test, Simultaneous HA/HS/HC Detection for Phenotype Identification Sickle Cell Disease Rapid Test, Simultaneous HA/HS/HC Detection for Phenotype Identification

Large Image :  Sickle Cell Disease Rapid Test, Simultaneous HA/HS/HC Detection for Phenotype Identification

Product Details:
Place of Origin: CHINA
Brand Name: HDRMEDICO
Certification: CE
Model Number: /
Payment & Shipping Terms:
Minimum Order Quantity: 500pcs
Price: Negotiable
Packaging Details: Carton
Delivery Time: 10-15days
Payment Terms: L/C,T/T,Westen Union,Money Gram,Paypal/VTB
Supply Ability: 100000pc/month
Contact Now Chat Now

Sickle Cell Disease Rapid Test, Simultaneous HA/HS/HC Detection for Phenotype Identification

Description
Product Name: Sickle Cell Disease Rapid Test Material: Plastic
Product Category: In Vitro Diagnosis Package: 25T/BOX
Function: Detection Storage: 2–30°C In Sealed Pouch
Highlight:

Sickle Cell Disease rapid test kit

,

HA HS HC phenotype detection test

,

Simultaneous hemoglobin variant test

Sickle Cell Disease Rapid Test, Simultaneous HA/HS/HC Detection for Phenotype Identification
This rapid test device is an in vitro diagnostic tool for the simultaneous detection of key hemoglobin phenotypes associated with Sickle Cell Disease: HA (normal hemoglobin), HS (sickle cell trait/carrier), and HC (sickle cell disease). Utilizing advanced immunochromatographic technology, it provides a rapid and reliable qualitative screening result from a small blood sample.
Intended Use & Application Scenarios
  • Newborn Screening: For early detection and risk assessment of sickle cell disease
  • Pre-marital / Pre-conception Screening: To evaluate genetic carrier status and inform family planning decisions
  • Clinical Symptom Triage: As an aid in diagnosing patients presenting with anemia, jaundice, unexplained pain (vaso-occlusive crisis), or growth delays
  • Multi-Scenario Adaptability: Suitable for at-home self-testing, initial screening in primary healthcare facilities, and large-scale procurement by public health departments for epidemiological surveillance
Core Features & Advantages
  • Triple-Target Synchronous Detection: Identifies HA, HS, and HC status in a single test, enabling precise phenotypic differentiation
  • High Sensitivity & Specificity: Engineered for accurate detection of hemoglobin variants, delivering stable and dependable results
  • Rapid & User-Friendly: Requires no specialized equipment; delivers clear visual results within minutes
  • Versatile Utility: Designed to meet diverse needs—from individual self-care to institutional screening programs

Contact Details
Sichuan Hundred Medcal Technology Co., Ltd.

Contact Person: Mr. Terry

Tel: 15008220675

Send your inquiry directly to us (0 / 3000)